Pharmacological study of therapeutic outcomes of carvedilol and co enzyme Q10 combination in isoprenaline-induced myocardial infarction in rats
Nora Mohamed El Shorbagi;
Abstract
Abstract:
The present study was designed to elucidate the potential pharmacological outcomes of carvedilol combination with co enzyme Q10 in isoprenaline-induced myocardial infarction in rats. Method: Carvedilol and/or co enzyme Q10 was given once daily for 14 consecutive days at doses of 10 mg/kg orally after administration of two doses of ISP (85 mg/kg; s.c.).:
The present study was designed to elucidate the potential pharmacological outcomes of carvedilol combination with co enzyme Q10 in isoprenaline-induced myocardial infarction in rats. Method: Carvedilol and/or co enzyme Q10 was given once daily for 14 consecutive days at doses of 10 mg/kg orally after administration of two doses of ISP (85 mg/kg; s.c.).:
Other data
| Title | Pharmacological study of therapeutic outcomes of carvedilol and co enzyme Q10 combination in isoprenaline-induced myocardial infarction in rats | Other Titles | دراسة دوائيه للتأثيرات الناتجة من إستخدام الكارفيديلول مع أنزيم كيو10 لعلاج موت عضلة القلب الناتج عن إستخدام أيزوبرينالين فى الجرذان | Authors | Nora Mohamed El Shorbagi | Issue Date | 2018 |
Recommend this item
Similar Items from Core Recommender Database
Items in Ain Shams Scholar are protected by copyright, with all rights reserved, unless otherwise indicated.